Cervical cancer is preventable, but it is the second most common gynecologic cancer worldwide and the third most common cancer in women in the United States (American College of Obstetricians and Gynecologists [ACOG], 2003 Cervical cancer screening with the Papanicolaou (Pap) smear has been identified as an effective method of prevention (Berman, 2006; Camillo, 2006; Farley, McBroom, & Zahn, 2005; Feldman, 2003; Sirovich, Feldman, & Goodman, 2008; Solomon, Breen, & McNeel, 2007) . The Pap smear detects precancerous lesions, for which effective treatments exist (Brink, Snijders, Meijer, Berkhof, & Verheijen, 2006; Feldman; Miller et al., 2003; Valdespino & Valdespino, 2006) . The five-year survival rate for localized cervical cancer is 92%, whereas women with invasive cervical cancer have a fiveyear relative survival rate of only 72% (ACS, 2008) . However, the relative survival rate is 100% if precancerous lesions are detected and treated (ACS).
A clinician recommendation is one of the strongest predictors of adherence with Pap smear testing (Markovic, Kesic, Topic, & Matejic, 2005; Ruffin, 2003) . Yet despite the recommendations depicted in Table 1 The purpose of this article is to review the optimal screening interval for lowrisk women who are 30 years of age or older and have an intact cervix. That age group is of particular interest because, although cervical cancer is diagnosed most commonly in the fifth decade of life, the average age of diagnosis is 47 years, and approximately half of the cases are diagnosed in women who are younger than 35 years of age (Waggoner, 2003) .
Paradigm Shift
High-r isk hu man papi l lomavir us (HPV) has been implicated in abnormal Pap smear results (Vo et al., 2004) Newer liquid-based cytologic tests (e.g., ThinPrep ® , Cytyc Corporation; Sure Path TM , BD Diagnostics) that facilitate HPV testing are in use (Walling, 2003) . They may be used alone or in conjunction with cytology (Denny & Wright, 2005) . The newer tests are more sensitive than the regular or conventional Pap smear (Biscotti et al., 2005; Mariani, 2004; Mayrand et al., 2007) .
Literature Review
A literature review for 2003-2008 was conducted to determine evidence-based practice recommendations regarding optimal cervical cancer screening intervals for women 30 years or older with an intact cervix. Nonexperimental studies are used in the discussion because no randomized clinical trials are available to assist in determining cervical cancer screening intervals (Van den Akker-van Marle, van Ballegooijen, & Habbema, 2003; Sirovich et al., 2008) . The reviewed studies did not provide the required evidence because: (a) most studies involved triennial cervical cancer screening using predominantly the conventional Pap smear with or without three previous consecutive negative results, and (b) only
